Fund code: 244

  • NAV $39.39 $0.03 / 0.07%
    24-Jun-2024
  • Inception 25-Sep-2001
  • Benchmark MSCI AC World Health Care Index
  • Aggregate assets
    (all series)
    $57.0M
    31-May-2024
  • MER 2.25%
    30-Nov-2023
  • Distributions Annually
  • Morningstar category Sector Equity
  • Also available through Trust US$ and Trust CDN$
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 31-May-2024

YTD 2024 2023 2022 2021 2020 2019 2018 2017
Fund 10.34 2.95 -7.74 19.22 9.18 18.30 13.85 10.93

Standard period returns (%) 31-May-2024

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr 10 yr Inception
Fund 2.63 3.63 12.49 15.05 6.21 9.21 10.06 6.12

Why invest in this fund?

  • Offers exposure to dynamic growth opportunities across the global health care sector.
  • Leverages Fidelity’s expertise in managing industry-specific funds.
  • See important fund suitability notice*

Risk measures (%) 31-May-2024

Fund
Annualized standard deviation 12.29
Beta 1.07
0.93

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

30-Apr-2024

Country mix (%)

30-Apr-2024

Sector mix (%)

30-Apr-2024
12 months ago Last month Current month
Pharma Products 27.4 27.0 27.8
Health Care Equipment & Supplies 22.2 23.1 25.5
Health Care Providers & Services 16.8 19.8 20.7
Life Sciences Tools & Services 23.2 17.0 14.7
Biotech. 6.1 7.0 6.7

Top ten holdings

  1. UnitedHealth Group
  2. Novo-Nordisk, Cl. B
  3. Eli Lilly and Company
  4. Thermo Fisher Scientific
  5. Roche Holding
  6. Stryker
  7. ICON plc
  8. Boston Scientific
  9. HCA Healthcare
  10. Regeneron Pharmaceuticals
Total number of holdings 44
Top ten holdings aggregate 49.9%
  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. Roche Holding
  4. Novo-Nordisk, Cl. B
  5. Stryker
  6. ICON plc
  7. Eli Lilly and Company
  8. Elevance Health
  9. Boston Scientific
  10. AstraZeneca
Total number of holdings 44
Top ten holdings aggregate 48.5%
  1. UnitedHealth Group
  2. Roche Holding
  3. Thermo Fisher Scientific
  4. Novo-Nordisk, Cl. B
  5. Eli Lilly and Company
  6. Elevance Health
  7. AbbVie
  8. Danaher
  9. AstraZeneca
  10. ICON plc
Total number of holdings 42
Top ten holdings aggregate 50.8%
  1. UnitedHealth Group
  2. Roche Holding
  3. Thermo Fisher Scientific
  4. Stryker
  5. Elevance Health
  6. ICON plc
  7. Danaher
  8. AbbVie
  9. Novo-Nordisk, Cl. B
  10. AstraZeneca
Total number of holdings 44
Top ten holdings aggregate 51.0%
View all